Michael Sardano - Sensus Healthcare General President
| SRTS Stock | USD 8.60 0.01 0.12% |
President
Michael Sardano is General President of Sensus Healthcare
| Age | 36 |
| Address | 851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487 |
| Phone | 561 922 5808 |
| Web | https://sensushealthcare.com |
Michael Sardano Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Sardano against Sensus Healthcare stock is an integral part of due diligence when investing in Sensus Healthcare. Michael Sardano insider activity provides valuable insight into whether Sensus Healthcare is net buyers or sellers over its current business cycle. Note, Sensus Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sensus Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Sardano over three months ago Disposition of 35 shares by Michael Sardano of Sensus Healthcare at 6.0 subject to Rule 16b-3 | ||
Michael Sardano over six months ago Acquisition by Michael Sardano of 20000 shares of Sensus Healthcare subject to Rule 16b-3 | ||
Michael Sardano over a year ago Purchase by Michael Sardano of 1000 shares of Sensus Healthcare |
Sensus Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.097 % which means that it generated a profit of $0.097 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1344 %, meaning that it created $0.1344 on every $100 dollars invested by stockholders. Sensus Healthcare's management efficiency ratios could be used to measure how well Sensus Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sensus Healthcare's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop (0.01) in 2024. At this time, Sensus Healthcare's Net Tangible Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 826.4 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 2.3 M in 2024.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| MBAMSHA CHE | Orthopediatrics Corp | 52 | |
| Gregory Odle | Orthopediatrics Corp | 54 | |
| Angelo Scopelianos | Axogen Inc | 68 | |
| Shaun MBA | Lucid Diagnostics | 42 | |
| Tyler Lipschultz | Orthofix Medical | 57 | |
| Aviva McPherron | Orthofix Medical | N/A | |
| Joseph Hauser | Orthopediatrics Corp | 41 | |
| Eric Weinberg | Rxsight | 63 | |
| James Cunniff | Electromed | 58 | |
| Kimberley Elting | Orthofix Medical | 59 | |
| David Bailey | Orthopediatrics Corp | 45 | |
| Shelley Thunen | Rxsight | 70 | |
| Ilya Goldshleger | Rxsight | 49 | |
| Erick DeVinney | Axogen Inc | 48 | |
| Kevin Kenny | Orthofix Medical | 59 | |
| Jon Serbousek | Orthofix Medical | 63 | |
| Daniel Gerritzen | Orthopediatrics Corp | 54 | |
| ChunHsien Tsai | Ainos Inc | 54 | |
| Gregg Sutton | SurModics | 64 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.097 |
Sensus Healthcare Leadership Team
Elected by the shareholders, the Sensus Healthcare's board of directors comprises two types of representatives: Sensus Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sensus. The board's role is to monitor Sensus Healthcare's management team and ensure that shareholders' interests are well served. Sensus Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sensus Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Magdalena Martinez, Chief Officer | ||
| Nicolas Soro, Chief Officer | ||
| Emiliano Sosa, Chief Officer | ||
| Benson Suen, VP Sales | ||
| Mark Nestor, Medical Board | ||
| Joseph Sardano, Chairman of the Board, CEO | ||
| Michael Sardano, General President | ||
| Stephanie Tipton, Vice Marketing | ||
| Javier Rampolla, Chief Officer | ||
| Clay Cockerell, Clinical Board | ||
| Sean Delaney, Vice Compliance |
Sensus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sensus Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.097 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.41 % | ||||
| Current Valuation | 119.05 M | ||||
| Shares Outstanding | 16.39 M | ||||
| Shares Owned By Insiders | 19.00 % | ||||
| Shares Owned By Institutions | 24.27 % | ||||
| Number Of Shares Shorted | 593.72 K | ||||
| Price To Earning | 4.30 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sensus Stock Analysis
When running Sensus Healthcare's price analysis, check to measure Sensus Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensus Healthcare is operating at the current time. Most of Sensus Healthcare's value examination focuses on studying past and present price action to predict the probability of Sensus Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensus Healthcare's price. Additionally, you may evaluate how the addition of Sensus Healthcare to your portfolios can decrease your overall portfolio volatility.